One Pager as on December 31, 2025
![]() | Prudent portfolio of investments across companies and sectors. |
![]() | Actively managed by professional fund managers for potential long term capital appreciation. |
![]() | Opportunity to participate in successful businesses through equity market. |
| Sector | MMMCF* | Nifty 500 Multicap 50:25:25 TRI |
| Financial Services | 30.93% | 29.72% |
| Healthcare | 13.04% | 7.96% |
| Capital Goods | 10.68% | 7.82% |
| Automobile And Auto Components | 7.51% | 7.11% |
| Information Technology | 7.10% | 7.25% |
*Mahindra Manulife Multi Cap Fund
Data as on December 31, 2025
| Security | % to Net Assets |
| Glenmark Pharmaceuticals Limited | 3.28% |
| Indus Towers Limited | 3.07% |
| ICICI Bank Limited | 3.07% |
| Divi's Laboratories Limited | 2.97% |
| Shriram Finance Limited | 2.51% |
| Polycab India Limited | 2.40% |
| UltraTech Cement Limited | 2.40% |
| Axis Bank Limited | 2.17% |
| Reliance Industries Limited | 2.11% |
| Piramal Finance Limited | 2.05% |
| Total | 26.03% |
| Fresh Additions | Complete Exits |
| Security | Security |
| SRF Ltd | Apollo Hospitals Enterprise Ltd |
| ICICI Prudential Asset Management Company | Persistent Systems Ltd |
| Ltd | Indian Bank |
| The Ramco Cements Ltd | Fortis Healthcare Ltd |
| Vedanta Ltd | - |
| Dalmia Bharat Ltd | - |
| Tega Industries Ltd | - |
| Tech Mahindra Ltd | - |
| DCB Bank Ltd | - |
| - | - |
Note: The companies/stock(s) referred above are only for the purpose of disclosure of significant portfolio changes during the month and should not be construed as recommendation to buy/sell/ hold. The fund manager may or may not choose to hold these companies/stocks, from time to time. Investors are requested to consult their financial, tax and other advisors before taking any investment decision(s). Data as on December 31, 2025
| Turnover Ratio (Last 1 year) | 1.01 |
| Standard Deviation | 14.67% |
| Beta | 1.00 |
| Sharpe Ratio# | 0.95 |
| Jenson's Alpha | 0.0649 |
#Risk-free rate assumed to be 5.67% (MIBOR as on 31-12-25) - Source: www.mmda.org
Note: As per AMFI guidelines for factsheet, the ratios are calculated based on month rolling returns
for last 3 years. Data as on December 31, 2025
^Benchmark ^^Additional Benchmark. CAGR – Compounded Annual Growth Rate. Inception/Allotment date: 11-May-17.
Past performance may or may not be sustained in future and should not be used as a basis of comparison with other investments.
Since inception returns of the scheme is calculated on face value of Rs. 10 invested at inception. The performance details provided above are of Growth Option under Regular Plan. Different Plans i.e Regular Plan and Direct Plan under the scheme has different expense structure. Mr. Vishal Jajoo is managing this fund since November 3, 2025, Ms. Fatema Pacha is managing this scheme since October 16, 2020 *Based on standard investment of Rs. 10,000 made at the beginning of the relevant period.
^Benchmark ^^Additional Benchmark. CAGR – Compounded Annual Growth Rate. Inception/Allotment date: 11-May-17.
Past performance may or may not be sustained in future and should not be used as a basis of comparison with other investments. Returns greater than 1 year period are compounded annualized. For SIP returns, monthly investment of equal amounts invested on the 1st business day of every month has been considered. CAGR Returns (%) are computed after accounting for the cash flow by using the XIRR method (investment internal rate of return).
^Benchmark CAGR – Compounded Annual Growth Rate.
Past performance may or may not be sustained in future and should not be used as a basis of comparison with other investments. The performance details provided above are of Growth Option under Regular Plan. Different Plans i.e Regular Plan and Direct Plan under the scheme has different expense structure. Mr. Vishal Jajoo manages 1 scheme, Ms. Fatema Pacha
manages 8 schemes and Mr. Manish Lodha manages 10 schemes each of Mahindra Manulife Mutual Fund. The performance data for the schemes which have not completed one year has not been provided.
$Note: Pursuant to notice cum addendum no. 52/2025, Fund Manager of the scheme has been changed with effect from January 01, 2026.
#Note: Pursuant to notice cum addendum no. 50/2025, the Benchmark of Mahindra Manulife Manufacturing Fund has been revised from ‘BSE India Manufacturing TRI’ to ‘Nifty India Manufacturing TRI’ with effect from December 22, 2025.
Note: The performance data of Mahindra Manulife Value Fund has not been provided as the scheme has not completed 1 year since inception. The said Scheme is managed by Mr. Krishna Sanghavi & Mr. Vishal Jajoo. The performance data of Mahindra Manulife Banking & Financial Services Fund has not been provided as the scheme has not completed 1 year since inception. The said Scheme is managed by Mr. Vishal Jajoo & Mr. Chetan Sanjay Gindodia.
This product is suitable for investors who are seeking*:
• Medium to Long term capital
appreciation.
• Investment predominantly in
equity and equity related securities
including derivatives.

*Investors should consult their financial advisers if in doubt about whether the product is suitable for them.